HPA-1a/b (P1A1/A2, Zwa/b): The odyssey of an alloantigen system

Immunohematology

Volumn 23, Issue 1, 2007, Pages 2-8

  Aster, Richard H ^a   Newman, Peter J ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GLYCOPROTEIN IIIA; HUMAN PLATELET ANTIGEN 1A; HUMAN PLATELET ANTIGEN 1B; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; ALLOIMMUNITY; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; BLOOD TRANSFUSION; CELLULAR IMMUNITY; HUMAN; HUMORAL IMMUNITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTEGRIN BETA3; ISOANTIGENS; POLYMORPHISM, GENETIC;

EID: 34247270912     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Zucker MB, Ley AB, Borrelli J, Mayer K, Firmat J. Thrombocytopenia with a circulating platelet agglutinin, platelet agglutinin, platelet lysin and clot retraction inhibitor. Blood 1959;14:148-61.
2. van Loghem JjJ, Dorfmeijer H, Van Hart M, Schreuder F. Serological and genetical studies on a platelet antigen (Zw). Vox Sang 1959;4:161-9.
3. Shulman NR, Aster RH, Leitner A, Hiller MC. Immunoreactions involving platelets. V. Post-transfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen. A proposed mechanism for thrombocytopenia and its relevance in "autoimmunity." J Clin Invest 1961;40:1597-620.
4. Shulman NR, Aster RH, Pearson HA, Hiller MC. Immunoreactions involving platelet. VI. Reactions of maternal isoantibodies responsible for neonatal purpura. Differentiation of a second platelet antigen system. J Clin Invest 1962;41:1059-69.
5. Van Der Weerdt CM, Veenhoven-Vonriesz LE, Nijenhuis LE, Van Loghem J. The Zw blood group system in platelets. Vox Sang 1963;8:513-30.
6. von dem Borne AE, Decary E Nomenclature of platelet-specific antigens. Hum Immunol 1990;29: 1-2.
7. Covas DT, Delgado M, Zeitune MM, Guerreiro JF, Santos SE, Zago MA. Gene frequencies of the HPA-1 and HPA-2 platelet antigen alleles among the Amerindians. Vox Sang 1997;73:182-4.
8. Kim HO, Jin Y, Kickler TS, Blakemore K, Kwon OH, Bray PF. Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations. Transfusion 1995;35:863-7.
9. Chang YW, Mytilineos J, Opelz G, Hawkins BR. Distribution of human platelet antigens in a Chinese population. Tissue Antigens 1998;51: 391-3.
10. Shulman NR, Jordan JV. Platelet immunology. In: Colman RW HJ, Marder VJ, Salzman EW, eds. Hemostasis and thrombosis. Philadelphia: JB Lippincott, 1987:452-529.
11. Newman PJ, McFarland JG, Aster RH. Alloimmune thrombocytopenias. In: J Loscalzo AS, ed. Thrombosis and Hemorrhage. Philadelphia: JB Lippincott, 2003:441-56.
12. Adner MM, Fisch GR, Starobin SG, Aster RH. Use of "compatible" platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura. N Engl J Med 1969;280:244-7.
13. A1 from platelets in Glanzmann's thrombasthenia. J Clin Invest 1978; 61:1225-31.
14. A1. Mol Immunol 1979;16:353-60.
15. A1: localization to a 17,000-dalton polypeptide. Mol Immunol 1985;22:719-29.
16. Fitzgerald LA, Steiner B, Rall SC Jr, Lo SS, Phillips DR. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin." J Biol Chem 1987;262:3936-9.
17. Newman PJ, Kawai Y, Montgomery RR, Kunicki TJ. Synthesis by cultured human umbilical vein endothelial cells of two proteins structurally and immunologically related to platelet membrane glycoproteins IIb and IIIa. J Cell Biol 1986;103: 81-6.
18. Giltay JC, Leeksma OC, von dem Borne AE, van Mourik JA. Alloantigenic composition of the endothelial vitronectin receptor. Blood 1988;72:230-3.
19. A1) on human vascular smooth muscle cells and foreskin fibroblasts: a study on normal individuals and a patient with Glanzmann's thrombasthenia. Blood 1989;74:965-70.
20. Newman PJ, Gorski J, White GC 2nd, Gidwitz S, Cretney CJ, Aster RH. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest 1988;82: 739-43.
21. A2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989;83:1778-81.
22. A and Bak alloantigenic epitopes. Blood 1991;78:681-7.
23. b alloantigen system. Blood 1990;75:2343-8.
24. b alloantigen system. J Clin Invest 1992;90:2038-43.
25. Santoso S, Kalb R, Walka M, Kiefel V, Mueller-Eckhardt C, Newman PJ. The human platelet alloantigens Br(a) and Br(b) are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2). J Clin Invest 1993; 92:2427-32.
26. McFarland JG, Aster RH, Bussel JB, Gianopoulos JG, Derbes RS, Newman PJ. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. Blood 1991; 78:2276-82.
27. Skogen B, Bellissimo DB, Hessner MJ, et al. Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion 1994;34:955-60.
28. Calvete JJ, Henschen A, Gonzalez-Rodriguez J. Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the beta-subunits of the integrin family. Biochem J 1991;274(Pt 1):63-71.
29. Flug F, Espinola R, Liu LX, et al. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope. Blood 1991;77:1964-9.
30. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004;432:59-67.
31. Valentin N, Visentin GP, Newman PJ. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response. Blood 1995;85:3028-33.
32. Reznikoff-Etievant MF, Muller JY, Julien F, Patereau C. An immune response gene linked to MHC in man. Tissue Antigens 1983;22:312-4.
33. a is strongly associated with HLA-B8 and DR3. Tissue Antigens 1985;26:71-6.
34. Valentin N, Vergracht A, Bignon JD, et al. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol 1990;27:73-9.
35. a): association with HLA-DRw52a is not 100%. Transfus Med 1992;2:251.
36. Maslanka K, Yassai M, Gorski J. Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia. J Clin Invest 1996;98:1802-8.
37. A2). Hum Immunol 1992;34:253-6.
38. Wu S, Maslanka K, Gorski J. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses. J Immunol 1997;158: 3221-6.
39. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-4.
40. Vijayan KV, Liu Y, Souza S, Thiagarajan P, Bray PE Fibrinogen and prothrombin binding is enhanced to the Pro33 isoform of purified integrin alphaIIbbeta3. J Thromb Haemost 2006;4:905-6.
41. Bennett JS, Catella-Lawson F, Rut AR, et al. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets. Blood 2001;97:3093-9.
42. Meiklejohn DJ, Urbaniak SJ, Greaves M. Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding. Br J Haematol 1999;105:664-6.
43. Gardemann A, Humme J, Strieker J, et al. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thromb Haemost 1998;80: 214-7.
44. Salido E, Martin B, Barrios Y, et al. The PlA2 polymorphism of the platelet glycoprotein IIIA gene as a risk factor for acute renal allograft rejection. J Am Soc Nephrol 1999;10:2599-605.
45. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997;349:385-8.
46. Feng D, Lindpaintner K, Larson MG, et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999;19:1142-7.
47. 2 polymorphism. Br J Haematol 1997;99:801-7.
48. Vijayan KV, Liu Y, Dong JF, Bray PF. Enhanced activation of mitogen-activated protein kinase and myosin light chain kinase by the Pro33 polymorphism of integrin beta 3. J Biol Chem 2003;278:3860-7.
49. Vijayan KV, Liu Y, Sun W, Ito M, Bray PF. The Pro33 isoform of integrin beta3 enhances outside-in signaling in human platelets by regulating the activation of serine/threonine phosphatases. J Biol Chem 2005;280:21756-62.